These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 1746476

  • 1. Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.
    Mauskopf JA, Wenger TL.
    Am J Cardiol; 1991 Dec 15; 68(17):1709-14. PubMed ID: 1746476
    [Abstract] [Full Text] [Related]

  • 2. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children.
    Woolf AD, Wenger T, Smith TW, Lovejoy FH.
    N Engl J Med; 1992 Jun 25; 326(26):1739-44. PubMed ID: 1594015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study.
    Hickey AR, Wenger TL, Carpenter VP, Tilson HH, Hlatky MA, Furberg CD, Kirkpatrick CH, Strauss HC, Smith TW.
    J Am Coll Cardiol; 1991 Mar 01; 17(3):590-8. PubMed ID: 1993775
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The monitoring of plasma digoxin levels during acute digitalis poisoning treated with Fab anti-digoxin fragments].
    Milani L, Bizzaro N, Sanson A.
    G Ital Cardiol; 1992 Jan 01; 22(1):97-101. PubMed ID: 1624074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Which cardiac disturbances should be treated with digoxin immune Fab (ovine) antibody?
    Marchlinski FE, Hook BG, Callans DJ.
    Am J Emerg Med; 1991 Mar 01; 9(2 Suppl 1):24-8; discussion 33-4. PubMed ID: 1997018
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ, Jones AL.
    Drug Saf; 2004 Mar 01; 27(14):1115-33. PubMed ID: 15554746
    [Abstract] [Full Text] [Related]

  • 15. [Report of experiences in the treatment of 16 cases of severe glycoside poisoning with digitalis antibody fragments (Fab)].
    Smolarz A, Roesch E, Lenz H, Neubert P, Abshagen U.
    Z Kardiol; 1984 Feb 01; 73(2):113-9. PubMed ID: 6719984
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Experience with digoxin immune Fab (ovine) in patients with renal impairment.
    Wenger TL.
    Am J Emerg Med; 1991 Mar 01; 9(2 Suppl 1):21-3; discussion 33-4. PubMed ID: 1997017
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oleander poisoning: treatment with digoxin-specific Fab antibody fragments.
    Shumaik GM, Wu AW, Ping AC.
    Ann Emerg Med; 1988 Jul 01; 17(7):732-5. PubMed ID: 3382077
    [Abstract] [Full Text] [Related]

  • 20. [Digitalis poisoning in children. Treatment with anti-digoxin Fab antibody fragments. Apropos of a case and a discussion of therapeutic indications].
    Jouk PS, Danel V, Bovier-Lapierre M, Frappat P, Barret L, Rossignol AM, Bost M.
    Pediatrie; 1986 Jul 01; 41(3):237-42. PubMed ID: 3774436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.